Jussi Sipilä
MD, BSocSci
jussi.sipila@utu.fi |
Huntington's disease; Neurodegenerative diseases; Clinical epidemiology
4 of 13
- Comorbidities in patients with Unverricht-Lundborg disease (EPM1) (2022)
- Acta Neurologica Scandinavica
- Finnish multiple sclerosis patients treated with cladribine tablets: a nationwide registry study (2022)
- Multiple Sclerosis and Related Disorders
- Impact of Oral Anticoagulation and Adenosine Diphosphate Inhibitor Therapies on Short-term Outcome of Traumatic Brain Injury (2022)
- Neurology
- Miksi MS-tauti yleistyy? (2022)
- Duodecim
- Parkinsonin taudin epidemiologia ja genetiikka Suomessa (2022)
- Duodecim
- Prognosis of patients with operated chronic subdural hematoma (2022)
- Scientific Reports
- Regarding: High Correlations Among Worldwide Prevalences of Dementias, Parkinson's Disease, Multiple Sclerosis and Motor Neuron Diseases Indicate Common Causative Factors (2022)
- Neuroscience Insights
- Safety of alemtuzumab in a nationwide cohort of Finnish multiple sclerosis patients (2022)
- Journal of Neurology
- SEZ6L2 Antibody-Associated Cerebellar Ataxia Responsive to Sequential Immunotherapy (2022)
- Neurology, Neuroimmunology and Neuroinflammation
- Case fatality of hospital-treated intracerebral hemorrhage in Finland - A nationwide population-based registry study (2021)
- Journal of the Neurological Sciences
UTU Research Portal